BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35803850)

  • 21. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
    Polesie S; Gillstedt M; Paoli J; Osmancevic A
    Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway.
    Juzeniene A; Micu E; Porojnicu AC; Moan J
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):821-7. PubMed ID: 21707773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
    Goldstein AM; Fraser MC; Clark WH; Tucker MA
    J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway.
    Thune I; Olsen A; Albrektsen G; Tretli S
    Int J Cancer; 1993 Oct; 55(4):555-61. PubMed ID: 8406981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
    Randi G; Naldi L; Gallus S; Di Landro A; La Vecchia C;
    J Invest Dermatol; 2006 Sep; 126(9):2106-10. PubMed ID: 16645584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
    Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
    Int J Cancer; 1999 Mar; 80(5):646-51. PubMed ID: 10048960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
    Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of node mapping differ for axial and extremity primary cutaneous melanoma: A case for a more selective use of pre-operative imaging.
    Fitzgerald TL; Gronet EM; Atluri P; Zervos EE; Wong JH
    Surgeon; 2016 Aug; 14(4):190-5. PubMed ID: 25563068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
    Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
    Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
    Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
    J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
    J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.
    Thörn M; Bergström R; Adami HO; Ringborg U
    Am J Epidemiol; 1990 Dec; 132(6):1066-77. PubMed ID: 2260538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations.
    Bucchi L; Mancini S; Zamagni F; Crocetti E; Dal Maso L; Ferretti S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Biggeri A; Stanganelli I; Falcini F;
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):293-302. PubMed ID: 36181283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
    Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new computerized methodology to analyse tumour site in relation to phenotypic traits and epidemiological characteristics of cutaneous malignant melanoma.
    Gillgren P; Brattström G; Djureen Mårtensson E; Frisell J; Palmgren J; Ringborg U; Hansson J
    Br J Dermatol; 2002 Jun; 146(6):1023-30. PubMed ID: 12072071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
    Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
    Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
    Lyth J; Carstensen J; Synnerstad I; Lindholm C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant melanoma: reduced risk associated with early childbearing and multiparity.
    Lambe M; Thörn M; Sparén P; Bergström R; Adami HO
    Melanoma Res; 1996 Apr; 6(2):147-53. PubMed ID: 8791273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival in 31 670 patients with thin melanomas: a Swedish population-based study.
    Isaksson K; Mikiver R; Eriksson H; Lapins J; Nielsen K; Ingvar C; Lyth J
    Br J Dermatol; 2021 Jan; 184(1):60-67. PubMed ID: 32133615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
    Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
    Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.